series-b
Stage
1
Investors
About
Omeros Corporation is a biopharmaceutical company focused on discovering and developing novel therapeutics, including small-molecule and protein drugs that target previously untapped receptors and enzymes for diseases with significant unmet medical needs.
Explore Omeros Corporation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.